Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer launches POC (point-of-care) CO-oximetry blood gas system:

This article was originally published in Clinica

Executive Summary

Bayer has launched worldwide its new Rapidpoint 405 critical care blood gas analyser. The point of care system offers a fully integrated CO-oximetry module along with five new haemoglobin tests for the assessment of medical emergencies such as hypoxia, septic shock, multiple organ failure and acute respiratory distress syndrome. The system, which can be monitored remotely from a central laboratory, also offers electrolyte, pH, glucose and haematocrit testing. The company has also received US FDA approval for its Acensia Breeze blood glucose monitor for diabetics, which it plans to launch in the third quarter.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel